GIA
AMAG

Gargoyle Investment Advisor’s AMAG Pharmaceuticals AMAG Stock Holding History

Gargoyle Investment Advisor’s Portfolio AMAG Stock Details AMAG Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-10,127
Closed -$186K – 201
2017
Q2 		$186K Hold
10,127
– – 0.07% 172
2017
Q1 		$228K Sell
10,127
-1,369
-12% -$32.8K 0.09% 173
2016
Q4 		$400K Buy
11,496
+2,528
+28% +$75.5K 0.16% 143
2016
Q3 		$220K Buy
+8,968
New +$224K 0.08% 177
2015
Q4 		– Sell
-8,894
Closed -$353K – 187
2015
Q3 		$353K Buy
+8,894
New +$552K 0.14% 155

Other funds holding AMAG

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
PAI
Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
CCM
Camber Capital Management Boston, Massachusetts $1.07B AUM 8.19% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Millennium Management
Millennium Management New York $240B AUM 35.51% 1-Year Est. Return
LSV Asset Management
LSV Asset Management Chicago, Illinois $46.4B AUM 27.74% 1-Year Est. Return
D.E. Shaw & Co
D.E. Shaw & Co New York $166B AUM 43.98% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return

Gargoyle Investment Advisor's AMAG Position: Q3 2017 in Review

Gargoyle Investment Advisor sold out of AMAG Pharmaceuticals (AMAG) in Q3 2017, closing a stake of 10,127 shares — an estimated $186K sold.

Gargoyle Investment Advisor first reported a position in AMAG in Q3 2015 and held it in 5 quarters. The position peaked at $400K in Q4 2016. 187 funds tracked by Wall St. Rank hold AMAG as of Q3 2017.

  • Gargoyle Investment Advisor reported no remaining AMAG Pharmaceuticals position as of Q3 2017 after selling out during the quarter.
  • Gargoyle Investment Advisor sold 10,127 AMAG Pharmaceuticals shares in Q3 2017, an estimated $186K.
  • Gargoyle Investment Advisor first reported a position in AMAG Pharmaceuticals in Q3 2015 and held it in 5 quarters.
  • Gargoyle Investment Advisor's AMAG Pharmaceuticals position peaked at $400K in Q4 2016.
  • 187 funds tracked by Wall St. Rank held AMAG Pharmaceuticals as of Q3 2017.

Based on Gargoyle Investment Advisor's 13F filing for Q3 2017, filed 13 Nov 2017.